TO describe a case of exudative macular detachment secondary to peripheral exudative chorioretinopathy with a favorable anatomic and visual outcome following treatment with intravitreal bevacizumab.
Methods
The medical records of a patient with peripheral exudative chorioretinopathy were reviewed.
Results
Macular reattachment was achieved with a corresponding visual acuity improvement that was maintained over an uncomplicated 17-month clinical course.
Conclusions
Bevacizumab may be an effective treatment option for exudative macular detachment secondary to peripheral exudative hemorrhagic chorioretinopathy.
CollaerN., JamesC.Peripheral exudative and hemorrhagic chorio-retinopathy: the peripheral form of age-related macular degeneration? Report on 2 cases. Bull Soc Belge Ophtalmol2007; 305: 23–6.
5.
SarksS.H.New vessel formation beneath the retinal pigment epithelium in senile eyes. Br J Ophthalmol1973; 57: 951–65.
6.
PoosR.Y., TreseM.T.Chorioretinal juncture; vascularization of Bruch's membrane in peripheral fundus. Arch Ophthalmol1982; 100: 1492–503.
